---
figid: PMC3736525__ECAM2013-705121.003
figtitle: Lycopene induces cell-cycle arrest and apoptosis
organisms:
- Nicotiana tabacum
- Glycine max
- Solanum lycopersicum
- Diaporthe sclerotioides
- Allium sativum
- Citrus x paradisi
- Melia azedarach
- Carica papaya
- Citrullus lanatus subsp. vulgaris
- Prunus armeniaca
- Psidium guajava
- Serenoa repens
- Mus musculus
- Rattus norvegicus
- Cricetulus griseus
- Cricetus cricetus
- Homo sapiens
- Canis lupus familiaris
organisms_ner:
- Cricetulus griseus
- Canis lupus familiaris
- Homo sapiens
- Rattus norvegicus
- Mus musculus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC3736525
filename: ECAM2013-705121.003.jpg
figlink: /pmc/articles/PMC3736525/figure/fig3/
number: F3
caption: Lycopene induces cell-cycle arrest and apoptosis. Growth factors, such as
  PDGF and IGF, enhance cell survival by protecting cells from apoptosis. Lycopene
  blocks cell-cycle progression from G1 to S phase, predominantly by reducing the
  levels of cyc D and E and subsequently inactivating CDK4 and 2 and reducing the
  phosphorylation of Rb. Furthermore, lycopene increases the levels of the CDK inhibitors
  p21 and p27 and the tumour suppressor p53 and reduces levels of SKP2 (leaf panel).
  Lycopene promotes apoptosis by decreasing Bcl-2, BclXL  and survivin expression,
  increasing the levels of the proapoptotic proteins Bax, Bad, Bim, and Fas ligand,
  and activating caspases 8, 9, and 3 (right panel). Lycopene can also block growth
  factor-mediated antiapoptotic signals by directly inhibiting the binding of growth
  factors to their receptors or by inhibiting the downstream PI3K-AKT pathway. Lycopene
  can elicit AKT-induced cell-cycle arrest and apoptosis through the phosphorylation
  and inactivation of GSK3β, p21, p27, Bad, and caspase 9, as well as the inactivation
  of p53 via Mdm2.
papertitle: Multiple Molecular and Cellular Mechanisms of Action of Lycopene in Cancer
  Inhibition.
reftext: Cristina Trejo-Solís, et al. Evid Based Complement Alternat Med. 2013;2013:705121.
year: '2013'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9356353
figid_alias: PMC3736525__F3
figtype: Figure
redirect_from: /figures/PMC3736525__F3
ndex: b88c151c-df05-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC3736525__ECAM2013-705121.003.html
  '@type': Dataset
  description: Lycopene induces cell-cycle arrest and apoptosis. Growth factors, such
    as PDGF and IGF, enhance cell survival by protecting cells from apoptosis. Lycopene
    blocks cell-cycle progression from G1 to S phase, predominantly by reducing the
    levels of cyc D and E and subsequently inactivating CDK4 and 2 and reducing the
    phosphorylation of Rb. Furthermore, lycopene increases the levels of the CDK inhibitors
    p21 and p27 and the tumour suppressor p53 and reduces levels of SKP2 (leaf panel).
    Lycopene promotes apoptosis by decreasing Bcl-2, BclXL  and survivin expression,
    increasing the levels of the proapoptotic proteins Bax, Bad, Bim, and Fas ligand,
    and activating caspases 8, 9, and 3 (right panel). Lycopene can also block growth
    factor-mediated antiapoptotic signals by directly inhibiting the binding of growth
    factors to their receptors or by inhibiting the downstream PI3K-AKT pathway. Lycopene
    can elicit AKT-induced cell-cycle arrest and apoptosis through the phosphorylation
    and inactivation of GSK3β, p21, p27, Bad, and caspase 9, as well as the inactivation
    of p53 via Mdm2.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Igbp1
  - Igf1r
  - Irs1
  - Cdk6
  - Cdk4
  - Gsk3b
  - Bid
  - Skp2
  - Diablo
  - Bcl2
  - Mdm2
  - Bad
  - Tp53
  - IGBP1
  - FASLG
  - IGF1R
  - IRS1
  - CDK6
  - CDK4
  - GSK3B
  - BID
  - SKP2
  - DIABLO
  - BCL2
  - CDKN1B
  - MDM2
  - BAD
  - CDKN1A
  - TP53
  - IGF1
  - FAS
  - CASP1
  - CASP2
  - CASP4
  - CASP5
  - CASP6
  - CASP8
  - CASP9
  - CASP10
  - CASP12
  - CASP14
  - CASP3
  - CASP7
  - CYCS
  - UXT
  - E2F1
  - E2F2
  - E2F3
  - E2F4
  - E2F5
  - E2F6
  - E2F7
  - E2F8
  - AKT1
  - AKT2
  - AKT3
  - IFI27
  - PSMD9
  - ZNRD2
  - DCTN6
  - TMED7
  - H3P23
  - TCEAL1
  - NSG1
  - H3P16
  - TP63
  - TP73
  - WARS1
  - Igf1
  - Faslg
  - Defb1
  - Akt1
  - Cdkn1b
  - Tmed7
  - Kras
  - Fasl
  - Ppia-ps1
  - Tarbp2
  - Casp9
  - Dctn6
  - Psmd9
  - Cdkn1a
  - Nsg1
  - Tpt1
  - Tceal1
  - Trp53
  - Gabrg2
  - Fas1
  - FASN1
  - cyc
  - CycE
  - Cyt-c-d
  - Cyt-c-p
  - cype
  - CycD
  - sgg
  - Axn
  - gskt
  - LanB2
  - anon-70Db
  - PrBP
  - Dronc
  - ebi
  - E2f2
  - E2f1
  - Akt
  - dbo
  - Debcl
  - DCTN6-p27
  - dap
  - CG9588
  - cass
  - p53
  - betaTub60D
  - hth
  - anon-70Dc
  - igbp1
  - igfn1.2
  - faslg
  - casp8
  - irs1
  - ndr2
  - cycsb
  - cdk6
  - cdk4
  - gsk3ba
  - birc5a
  - bida
  - skp2
  - diabloa
  - chmp2a
  - mdm2
  - badb
  - cdkn1a
  - tp53
---
